These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37836471)

  • 1. Transcriptomics Reveals the Mechanism of
    Tan Y; Tan S; Ren T; Yu L; Li P; Xie G; Chen C; Yuan M; Xu Q; Chen Z
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide from
    Wang L; Li C; Huang Q; Fu X
    J Agric Food Chem; 2020 Jan; 68(1):147-159. PubMed ID: 31826616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Hydroalcoholic Extract from
    Wu PH; Han SC; Wu MH
    Acta Cardiol Sin; 2020 Mar; 36(2):148-159. PubMed ID: 32201466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma.
    Jeong HW; Lee JW; Kim WS; Choe SS; Kim KH; Park HS; Shin HJ; Lee GY; Shin D; Lee H; Lee JH; Choi EB; Lee HK; Chung H; Park SB; Park KS; Kim HS; Ro S; Kim JB
    Diabetes; 2011 Feb; 60(2):496-506. PubMed ID: 21270261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
    Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
    Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grape seed procyanidin B2 ameliorates hepatic lipid metabolism disorders in db/db mice.
    Yin M; Zhang P; Yu F; Zhang Z; Cai Q; Lu W; Li B; Qin W; Cheng M; Wang H; Gao H
    Mol Med Rep; 2017 Sep; 16(3):2844-2850. PubMed ID: 28677803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
    Qiao L; MacLean PS; You H; Schaack J; Shao J
    Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight.
    Jelinek D; Castillo JJ; Garver WS
    Gene; 2013 Sep; 527(1):65-70. PubMed ID: 23769925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse KLF11 regulates hepatic lipid metabolism.
    Zhang H; Chen Q; Yang M; Zhu B; Cui Y; Xue Y; Gong N; Cui A; Wang M; Shen L; Zhang S; Fang F; Chang Y
    J Hepatol; 2013 Apr; 58(4):763-70. PubMed ID: 23183531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor agonist decreases lipid accumulation by promoting hepatic fatty acid oxidation in db/db mice.
    Liu Y; Song A; Yang X; Zhen Y; Chen W; Yang L; Wang C; Ma H
    Int J Mol Med; 2018 Sep; 42(3):1723-1731. PubMed ID: 29901078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism.
    Ni HY; Yu L; Zhao XL; Wang LT; Zhao CJ; Huang H; Zhu HL; Efferth T; Gu CB; Fu YJ
    Phytomedicine; 2022 Apr; 98():153919. PubMed ID: 35104757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism.
    Kim SH; Hong SH; Park YJ; Sung JH; Suh W; Lee KW; Jung K; Lim C; Kim JH; Kim H; Park KS; Park SG
    Sci Rep; 2019 Feb; 9(1):1656. PubMed ID: 30733541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic mechanisms of Ganoderma lucidum polysaccharides F31 in db/db mice via RNA-seq and iTRAQ.
    Xiao C; Wu Q; Xie Y; Tan J; Ding Y; Bai L
    Food Funct; 2018 Dec; 9(12):6495-6507. PubMed ID: 30467564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low abundance of mitofusin 2 in dairy cows with moderate fatty liver is associated with alterations in hepatic lipid metabolism.
    Dong J; Loor JJ; Zuo R; Chen X; Liang Y; Wang Y; Shu X; Sun X; Jia H; Liu G; Wang Z; Li X; Li X
    J Dairy Sci; 2019 Aug; 102(8):7536-7547. PubMed ID: 31178189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
    Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.